Isolation and Biosynthesis of Phenazine–Polyketide Hybrids from Streptomyces sp. KIB-H483
Zhiyan Wang,Feng-Xian Yang,Chongxi Liu,Li Wang,Yuxin Qi,Minghang Cao,Xiaowei Guo,Jie Li,Xueshuang Huang,Jing Yang,Sheng-Xiong Huang
DOI: https://doi.org/10.1021/acs.jnatprod.2c00067
IF: 5.1
2022-05-14
Journal of Natural Products
Abstract:A phenazine-polyketide hybrid compound, nexphenazine A (<b>1</b>), was isolated from <i>Streptomyces</i> sp. KIB-H483. The bioinformatic analysis of the draft genome of the producing strain and gene inactivation experiments revealed that the biosynthesis of <b>1</b> involves a phenazine-polyketide hybrid gene cluster. The abolished production of <b>1</b> as well as the accumulation of shunt metabolites <b>4</b>-<b>7</b> in mutant strain <i>ΔnpzI</i> revealed the key role of the <i>npzI</i> gene, which encodes an NAD(P)H-dependent ketoreductase, in nexphenazine biosynthesis. The structures and absolute configurations of the isolated intermediates were established on the basis of spectroscopic data analysis, single-crystal X-ray diffraction, chiral chromatography, and chemical conversion experiments. NpzI exhibited stereochemical selectivity in reducing the carbonyl group of <b>4</b>. Nexphenazine biosynthesis is proposed to involve a condensation of the carboxyl group of phenazine with one molecule of methylmalonyl-CoA by a type I PKS, followed by a ketone reduction by NpzI and an unknown methylation reaction.
plant sciences,chemistry, medicinal,pharmacology & pharmacy